Scroll To Top
Search by Speciality

17th ECCO – 38th ESMO – 32nd ESTRO European Cancer Congress

RAI Amsterdam * | Amsterdam, NETHERLANDS
From 25 to 1199 EUR
Event Preview
This event
is Finished
Title: 17th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress
Specialty: , Medical Oncology, Urology
Dates: From Sep, 27, 2013 to Oct, 1, 2013
Location: Amsterdam, NETHERLANDS
Type: Conference
Registration Cost: From 25 to 1199 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Amsterdam, Netherlands.
General Info
Event Venue:

RAI Amsterdam *

Amsterdam, NETHERLANDS Visit the Venue to read more
Transportation Guide:

Amsterdam RAI is easy to reach by both public transport or by car and has ample parking facilities on and outside its site. Amsterdam RAI is situated 8 minutes from Amsterdam’s city centre and 15 minutes from Schiphol Airport.

  • By train: station Amsterdam RAI
  • By tram, metro or bus: from Amsterdam Central Station: tram 4, metro 51. From Amstel railway station: metro 51 and bus 65. From Amsterdam Sloterdijk station: metro 50.
  • By car: The RAI is signposted on roads signs on the ring road after approaching Amsterdam from the A1 motorway (Amersfoort/Amsterdam), the A2 (Utrecht/Amsterdam) or the A4 (Den Haag [The Hague]/Amsterdam). Amsterdam RAI is situated right next to the ring road (Exit 9). The RAI’s car parks are signposted immediately after leaving the ring road.

Participants registered for the entire duration of the European Cancer Congress are entitled to one free public transport ticket giving access to public transport in Amsterdam during the Congress and are encouraged to use public transport as much as possible.

Event Overview
Welcome message:

Our renowned biennial series of multidisciplinary European Cancer Congresses are recognised as the premier cancer meetings in Europe. At Stockholm in 2011, 15 931 participants from all disciplines experienced the strongest and most forward-focused scientific programme to date.

The 17th ECCO – 38th ESMO – 32nd ESTRO European Cancer Congress, Amsterdam, 27 September – 1 October 2013, will once again combine the united efforts of all partner organisations to continue positioning multidisciplinarity as the way forward to best improve the prevention, diagnosis, treatment and care of cancer patients. The recognised multidisciplinary setting of the Congress will provide ideal surroundings for participants to leverage knowledge, promote education and build awareness about oncology - placing the patient at the heart of all our efforts and discussions.

These are exciting times for the oncology community. Multidisciplinarity represents optimum professional efficiency in practice. However, as the management of cancer research, treatment and care becomes more complex, it is crucial that all key professional groups are able to contribute effectively to ensuring that professional decisions are evidence-based, patient-centred and reached by consensus.

In 2011, we had the largest number of abstracts ever submitted, and the highest amount of new data presented. And 2012 promises to be an even stronger, pioneering programme for showcasing the latest developments in practice-changing studies of new and significant scientific importance. This preliminary announcement provides you with just a taste of what is to come.

The Congress will also strive to further the role of multidisciplinary oncology by encouraging participation and interaction between all oncology professions, irrespective of their focus. We therefore strongly encourage involvement across disciplines and specialist fields and invite you to join our efforts to advance cancer treatment and care by ensuring your discipline or specialist field is well-represented. There is no better way to underpin the importance of your specialty and ensure it makes a tangible contribution in establishing standards for the field of oncology now and into the future.

We look forward to receiving your registration and hearing about your latest data, but most importantly, we look forward to the part you will play in ensuring that existing and future patients benefit from access to innovation, quality treatment and care at the European Cancer Congress in Amsterdam.

Cornelis van de Velde, Congress Chair, ECCO President
Martine Piccart, ESMO President
Cora Sternberg, Co-scientific Chair
John Yarnold, Co-scientific Chair
Marcel Verheij, National Organising Committee Chair

Registration Not yet available Register Now

MCI Amsterdam, the official housing partner for the European Cancer Congress 2013, has reserved a large number of hotel rooms in various hotels in different price categories.

The majority of the hotels are located in the city centre of Amsterdam, and the Amsterdam RAI can be reached by public transportation from all hotels.

As Amsterdam is a highly popular destination, we advise you to book your hotel accommodation as soon as possible. 
Individual reservations can be made online through this website as from 1 October 2012.

For group requests (more than 10 rooms), you can contact MCI Amsterdam directly.

For up-to-date availability and immediate confirmation, please book your room through the online booking site. If you prefer to use a hard copy reservation form, please contact the housing bureau. Processing a form received by fax or email may take up to 2 working days


MCI Amsterdam Office
Jan van Goyenkade
1075 HP Amsterdam
Tel:  +31 206793411
Fax: +31 206737306

Scientific Content Up to Date
Submission Info

With the submission of an abstract to the European Cancer Congress 2013, the first (presenting) author:

  • Certifies to be an investigator with a substantial involvement in the clinical study presented in the abstract.
  • Accepts responsibility for the accuracy of the submitted abstract (please proofread the abstract carefully prior to submission!).
  • Accepts to be the contact person for all correspondence about the abstract and inform co-authors about its status.
  • Confirms that all co-authors are aware of and agree to the content of the abstract and support the data presented.
  • Warrants that the data and conclusions presented in the abstract have not been presented or published at any meeting of 500 delegates or more prior to the European Cancer Congress 2013.
  • For important large studies, presented (in part) at previous meetings, authors are encouraged to provide updated data. Violation of this policy may result in a rejection of the submitted abstract.
  • Certifies that the information in the abstract is for exclusive presentation in the European Cancer Congress 2013 scientific programme and will not be presented as such during the conference at any industry-related satellite symposia.
  • States that for all studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority and properly informed consent given where appropriate.
  • Abstracts that include clinical trial data include the following information in the body of the abstract:
    Trial abbreviation, Trial Registry Number or ID background, Objective, Design, Population studied (including sample size), Intervention, Outcome measure (s), Analysis, Trial status, Trial sponsor(s).
  • Identifies any financial interest in products or processes described in the abstract. The presenting author is requested to tick the “Conflict of interest” box when submitting the abstract and to provide disclosure of interests and relationships through the abstract submission programme. This includes stock ownership, membership on an advisory board or board of directors, corporate-sponsored research, or other substantive relationships. (See detailed Conflict of Interest Policy below)
  • Releases the copyright to ECCO and gives permission for the abstract, when selected for presentation, to be published in the European Cancer Congress 2013 Abstract book with the European Journal of Cancer Supplement (in printed and electronic format), as well as on the ECCO website.
Editorial Guidelines for Presented Content:

a. Abstract format

  • The title of the abstract should be brief, and in sentence case, objectively describing the study. Do not use non-standard abbreviations and commercial names (generic names only).
  • No more than 10 authors can be listed with institutional affiliations, cities and countries only. Mailing addresses and academic degrees should not be mentioned in the author’s list. For cooperative study groups, you may give the name of the group instead of individual institutional affiliations or include the name of the group in the title of the abstract.
  • Abstracts should be structured in such a way as to include the following 4 sections
    • Background: an introductory sentence indicating the purpose of the study
    • Material and methods: a brief description of pertinent experimental procedures
    • Results: a summary of the results of the research
    • Conclusions: a statement of the main conclusions
  • The on-line abstract submission procedure will not accept abstracts that exceed 2.500 characters (body of the abstract, including spaces and table).
  • Only one data table is permitted in the body of the abstract. Illustration and figures are not allowed and will be deleted if submitted.
  • Abbreviations may be used if standard or if spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase). Compounds should be mentioned with the generic name, in lower cases. Commercial names are admitted in the text, with an ®, and if in brackets following the generic name, i.e. “generic (Commercial ®)”.
  • The abstract must be submitted in good English. The Scientific Committee reserve the right to reject those abstracts which are presented in poor English, or may request an immediate revision by the presenter.


b. Abstract submission procedure Essential information

  • When finished with the online submission, click the “FINAL SUBMISSION” button for the final submission of your abstract. As a confirmation of your submission, a message will appear on the screen informing you the abstract has been successfully submitted to our database.
  • If you need to edit your abstract at a later stage please click 'SAVE AND CLOSE'. This button allows you to update your abstract before final submission. 

    Please note: after clicking 'SAVE AND CLOSE', your abstract is NOT submitted. You need to return to the abstract submission page, finalise your abstract and click 'FINAL SUBMISSION'.

  • Within 48 hours of submission, the presenting author will receive an e-mail to confirm that ECCO has received the abstract. This confirmation of abstract does not mean your abstract has been selected for presentation.
  • In case the confirmation from the European Cancer Congress 2013 Secretariat is not received, please contact the secretariat ( within one week after the submission of the abstract.
  • Submitting an abstract for presentation in the European Cancer Congress 2013 does not constitute registration for the congress. Abstract presenters must register to attend the European Cancer Congress 2013 by following the instructions for registration on the website.


Presentation preference
Oral, poster or no preference: the final decision on the presentation format will be made by the Scientific Committee.

Topic category
Please choose one main category and then select one sub category.

Authors have to provide 3 keywords (different from category). The Scientific Committee has the authority to re-categorise and re-key the abstract.

For questions regarding the on-line submission process, e-mail

Sponsors Exhibitors
General Info

You will find below the link to the core manual developed by ECCO, including key information such as deadlines, contact persons, regulations, etc.

In addition to this document, an online manual has been developed by our Exhibition Service Contractor, Gielissen. You will find the direct link to that online tool on page 6.

The online manual has integrated all useful and necessary information for you to plan your show & your presence at ECC 2013, including ECCO instructions, freight handling, RAI regulations, all catalogues & order forms, and others.

Please read carefully & distribute accordingly to any third-party partner involved in the exhibition of ECC 2013

Exhibition Floor plans
Organising Agency

ECCO - the European CanCer Organisation
Avenue E. Mounier 83 
B-1200 Brussels, Belgium 
Tel: +32 2 775 02 01 
Fax:+32 2 775 02 00

Event map
Revelant Events